Nordic Infucare started its journey as an entrepreneurial company with the desire to do things differently. Mats Bergryd founded the business to offer specialized treatments in a home environment, serving patients who suffer from chronic disease. He chose that niche as he, after 20 years in the industry, had identified a gap between what was possible to achieve with smart technology and pharmaceuticals, and the actual result. Mats concluded that there was an opportunity to increase the quality of life or patients with chronic disease by closing the gap, and that it would be good business for the one who succeeded.
Since the start in 2002 we have grown into a company with more than 100 employees. Today we are a part of the Air Liquide group, but the patient’s quality of life still guides all our actions.
Creative problem solvers
Something we all have in common at Nordic Infucare is that we like solving problems and that we are motivated by making a difference for the patients. There is no doubt in our minds that we harness the most of our employees’ creativity and top performances when we don’t lock them into processes but set them free to find their own solutions.
How will you CONTRIBUTE and GROW?
Nordic Infucare is seeking an experienced and results driven Key Account Manager to join our Special Care team in Norway and help make an impact in Pulmonology care.
In this role you'll be at the forefront of driving business growth in Norway by identifying and implementing new opportunities within the Pulmonology therapy area, with a focus on our new product, ARIKAYCE® (Amikacin Liposome Inhalation Suspension).
This is an exciting opportunity to create awareness of a new product in its early phase of adoption, and finding the right decision pathways for patient initiation. The role will suit someone with a strong background in pharmaceutical sales , with an ability to take ownership of their own workload and work in an autonomous manner.
This is a field based position so an openness to regular travel across Norway is essential.
Your main responsibilities :
Actively identify, engage, and collaborate with relevant stakeholders (HCPs, pharmacists, KOLs) to build awareness of NIC's product portfolio, with a focus on ARIKAYCE®.
Continuously analyze, plan, implement, and follow up on account plans and activities in line with strategy and budgets to ensure a return on investment.
Contribute to sales forecasting, set ambitious sales targets with the line manager, and report all activities in the CRM system
Maintain productive cooperation within the Nordic team, utilize the Nordic support organization, and interact with colleagues to identify business potential.
Collaborate on team training, attend external training, and maintain up-to-date academic and scientific knowledge to improve business performance.
Assist in adapting sales campaigns, invitations, and marketing materials for the local market.
Monitor sales trends and pricing, and provide assistance with tender processes within the area of responsibility.
Ensure strict adherence to all internal and external compliance rules and regulations, and effectively represent NIC in internal and external meetings and congresses.
Support with the wider Special Care team across the Nordic region as a whole when needed.
Are you a MATCH?
The ideal person for this role will be an accomplished sales professional with a strong background in the Pharmaceutical sector. You will need to be a team player, with an ability to work proactively and independently in the market.
We also look for:
A minimum of 5 years experience in pharmaceutical sales is essential
LMI examined
Any experience in the lung/pulmonary area (e.g. cystic fibrosis or lung infections) is desired.
Any experience working with product launches is beneficial.
Must have an openness to regular travel across Norway and occasionally to other Nordic countries to support the wider team (30+ days per year).
Excellent communication skills with fluency in both Norwegian and English
What we offer:
We have a competitive benefits package, and long term development opportunities within the business. Benefits include:
Competitive salary and bonus scheme
Company car
Private healthcare
Generous pension scheme
#LI-KM1
Our Differences make our Performance
At Air Liquide, we are committed to build a diverse and inclusive workplace that embraces the diversity of our employees, our customers, patients, community stakeholders and cultures across the world.
We welcome and consider applications from all qualified applicants, regardless of their background. We strongly believe a diverse organization opens up opportunities for people to express their talent, both individually and collectively and it helps foster our ability to innovate by living our fundamentals, acting for our success and creating an engaging environment in a changing world.

Air Liquide is a world leader in gases, technologies and services for industry and healthcare. Present in 72 countries with 67,800 employees, the Group serves more than 4 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the Group’s activities since its creation in 1902.
Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan for 2025, Air Liquide is targeting a global performance, combining financial and extra-financial dimensions. Positioned on new markets, the Group benefits from major assets such as its business model combining resilience and strength, its ability to innovate and its technological expertise. The Group develops solutions contributing to climate and the energy transition—particularly with hydrogen—and takes action to progress in areas of healthcare, digital and high technologies.
Air Liquide’s revenue amounted to more than 27.5 billion euros in 2023. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX 50, FTSE4Good and DJSI Europe indexes.